These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 2572243)
21. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension. Silke B; Guy S; Humphreys JE J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension. Beretta-Piccoli C; Ferrier C; Weidmann P J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818 [TBL] [Abstract][Full Text] [Related]
23. Combined alpha- and beta-receptor inhibition in the treatment of hypertension. Prichard BN Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891 [TBL] [Abstract][Full Text] [Related]
24. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects. Westheim A; Daae LN; Kierulf P; Brusletto B; Holme I; Syvertsen JO J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076 [TBL] [Abstract][Full Text] [Related]
25. The place of alpha blockers in the treatment of hypertension. Reid JL Clin Exp Hypertens; 1993 Nov; 15(6):1291-7. PubMed ID: 7903577 [TBL] [Abstract][Full Text] [Related]
26. The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension. Davey MJ Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):5S-8S. PubMed ID: 2871856 [TBL] [Abstract][Full Text] [Related]
31. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia]. Ponikowski P; Hańczycowa H; Sebzda T; Jurga M; Spring A; Rotter A; Jordanek P Wiad Lek; 1993 Apr; 46(7-8):250-4. PubMed ID: 7902632 [TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists. Reid JL; Vincent J Cardiology; 1986; 73(3):164-74. PubMed ID: 2872958 [TBL] [Abstract][Full Text] [Related]
33. Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more? Ligueros M; Unwin R; Wilkins M Clin Auton Res; 1991 Sep; 1(3):251-8. PubMed ID: 1687998 [TBL] [Abstract][Full Text] [Related]
34. Reversal of left ventricular hypertrophy by terazosin in hypertensive patients. Yasumoto K; Takata M; Yoshida K; Mikawa M; Tomoda F; Sasayama S J Hum Hypertens; 1990 Feb; 4(1):13-8. PubMed ID: 1971654 [TBL] [Abstract][Full Text] [Related]
36. [Pressure and metabolic effects of terazosin in essential hypertension]. Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256 [TBL] [Abstract][Full Text] [Related]
37. Serum lipoproteins during treatment with antihypertensive drugs. Weidmann P; de Courten M; Ferrari P; Böhlen L J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069 [TBL] [Abstract][Full Text] [Related]
38. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension. Young RA; Brogden RN Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495 [TBL] [Abstract][Full Text] [Related]
39. Alpha blockers: a reassessment of their role in therapy. Cauffield JS; Gums JG; Curry RW Am Fam Physician; 1996 Jul; 54(1):263-6, 269-70. PubMed ID: 8677841 [TBL] [Abstract][Full Text] [Related]
40. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers. Talseth T; Westlie L; Daae LN J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]